CID 11669221

Schembl3994102

Structural Information

Molecular Formula
C26H35N5O
SMILES
CN1CCC[C@@H](C1)CN2C3=CC=CC=C3N=C2CN(CCO)[C@H]4CCCC5=C4N=CC=C5
InChI
InChI=1S/C26H35N5O/c1-29-14-6-7-20(17-29)18-31-23-11-3-2-10-22(23)28-25(31)19-30(15-16-32)24-12-4-8-21-9-5-13-27-26(21)24/h2-3,5,9-11,13,20,24,32H,4,6-8,12,14-19H2,1H3/t20-,24-/m0/s1
InChIKey
JSIVRGPWVYZZRY-RDPSFJRHSA-N
Compound name
2-[[1-[[(3S)-1-methylpiperidin-3-yl]methyl]benzimidazol-2-yl]methyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]ethanol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

6
Patents

433.28415 Da
Monoisotopic Mass

2.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 434.29143 207.5
[M+Na]+ 456.27337 210.5
[M-H]- 432.27687 211.8
[M+NH4]+ 451.31797 214.0
[M+K]+ 472.24731 203.0
[M+H-H2O]+ 416.28141 193.8
[M+HCOO]- 478.28235 218.0
[M+CH3COO]- 492.29800 212.8
[M+Na-2H]- 454.25882 206.9
[M]+ 433.28360 203.9
[M]- 433.28470 203.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe